SGI-DNA Revenue and Competitors

Location

$175M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SGI-DNA's estimated annual revenue is currently $54.8M per year.(i)
  • SGI-DNA's estimated revenue per employee is $193,750
  • SGI-DNA's total funding is $175M.

Employee Data

  • SGI-DNA has 283 Employees.(i)
  • SGI-DNA grew their employee count by 55% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$50.8M3283%N/AN/A
Add Company

What Is SGI-DNA?

At SGI-DNA, we are committed to leveraging our unique and propriety DNA technologies into scientific solutions for accelerating and advancing research. Our ever-expanding suite of reagents and instrumentation systems are fueling novel and groundbreaking approaches for basic synthetic biology research, as well as biomedical and industrial applications. We?re converting our scientific breakthroughs into innovative products for scientists worldwide for the advancement of scientific research and drug discovery.

keywords:N/A

$175M

Total Funding

283

Number of Employees

$54.8M

Revenue (est)

55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SGI-DNA News

2022-04-19 - Comparing BioForce Nanosciences (OTCMKTS:BFNH) and ...

BioForce Nanosciences (OTCMKTS:BFNH – Get Rating) and Codex DNA ... The company was formerly known as SGI-DNA, Inc. and changed its name to...

2022-04-17 - Financial Contrast: Rapid Micro Biosystems (NASDAQ:RPID ...

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems ... The company was formerly known as SGI-DNA, Inc. and changed its name to...

2019-09-09 - SGI-DNA Secures $25M in Series A Financing

SGI-DNA, a San Diego, CA-based developer of synthetic genomics technologies and DNA data storage solutions, closed a $25m Series A financing. The round was led by Northpond Ventures, with participation from Oxford Finance and BroadOak Capital Partners. The company intends to use the funds for ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.4M31225%$140.1M
#2
$86.6M3304%N/A
#3
$107M38314%$71M
#4
$121.2M42711%N/A
#5
$159M4718%N/A